We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 82.50 | 80.00 | 85.00 | 82.50 | 82.50 | 82.50 | 184 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -3.77 | 11M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/8/2018 17:51 | Deep pockets though. And don't forget TexRAD has got a unique selling point - "TexRAD detects and measures ‘tumour complexity’ in medical images and reveals more information than is readily visible to the naked eye." Can you find even one other medical imaging company that can say that? | lr2 | |
19/8/2018 17:35 | But they haven't put their hands in their pockets yet. | ducatiman | |
19/8/2018 16:42 | And The Institute of Nuclear Medicine... | lr2 | |
19/8/2018 16:33 | True, and I guess you could say the same about Alliance Medical, Siemens, and the NHS. | lr2 | |
19/8/2018 16:10 | Ty LR2, key point for me was that a company like GE don't partner with a micro cap like fdbk unless they have conducted due diligence. | ducatiman | |
19/8/2018 15:07 | Short chat on Feedback starting around 32:45. | lr2 | |
19/8/2018 11:48 | Well said Bo. | ducatiman | |
19/8/2018 10:55 | ydder,you shouldn't be too concerned as it would seem you are now flat. Only time will tell if you made the correct decision. Yes, there are certainly questions to be answered, hopefully it won't be too long now before they are answered. | ducatiman | |
19/8/2018 03:47 | yes , whats your view on DC ,s abrupt departure ydder | botak54 | |
18/8/2018 20:18 | Strange isn't it ydder, we have some directors buying and others selling. Looks like a new v old battle. Do you have any views on Crabb's "abrupt" departure? Sacked or walked? | ducatiman | |
18/8/2018 18:30 | Have we considered what has happened in the (now vast) imaging analysis sector since Feedback was re-listed in 2014. There is rarely any discussion here about potential and actual competition in the field. Logically it would be surprising to find that that the thousands of other researchers in medical image analysis have made no significant progress. There are now a large number of business and projects in the medical imaging arena, just takes a few minutes googling...eg Isn't it worrying that even after four years only the research version of the software is being sold, since there must be a natural limit in how many research projects based on texture analysis can be supported, even globally? There has been some comment here on Mike Hayball's share sales. Mike was closely involved in the development of TexRad software and was for a couple of years a main board director of Feedback....David Crabb departed abruptly after a few months as CEO and in all these circumstances it is sobering to replay Alastair's podcast from November 2016 | ydderf | |
18/8/2018 15:50 | Duc, the trade was from Thursday and the price suggests it was a buy. Ash, I have absolutely no doubt about Balaji says. The product can also detect things that the human eye cannot. | lr2 | |
18/8/2018 12:36 | Was that late reported trade definitely a buy? Looks like Hayball sold a few more yesterday but if he wants out looks like there is someone mopping up. Roll on the day when there is no longer a ready supply! | ducatiman | |
18/8/2018 12:14 | LR2...thanks for that ,if it does what Balaji says at at no extra cost ie can utilise existing scans but give more accurate outcomes for patients then bingo. | ashtree2 | |
18/8/2018 02:56 | AI : The Next Big Thing. Here's half a dozen or so very bright guys showing you how NOT to run a discussion group / Q&A session. Balaji Ganeshan starts talking about TexRAD around the 15 minute mark so you might find that interesting. However, I get the feeling there are a few dinosaur radiologists in the audience who didn't grasp the fact that TexRAD can pinpoint features that cannot be seen by the human eye... or perhaps they just didn't want to acknowledge that (even to themselves). | lr2 | |
17/8/2018 18:03 | Big delayed buy from yesterday morning! | petekand | |
17/8/2018 17:47 | Cheers, Duc..and you. | gymratt | |
17/8/2018 16:58 | Disappointing day, good week. Wish I knew how many of his shares this guy is going to dump. Have a good weekend everyone. | ducatiman | |
17/8/2018 15:05 | I suspect guys like MH are on the way out soon and/or providing some liquidity to the market. His sold shares have already been picked up by others and hopefully into stronger hands so no issues of overhang, etc. Besides, the business case trumps sellers holding a few million shares. Short term annoyance really. | petekand | |
17/8/2018 14:56 | Ty for info ash. Perplexing indeed. Sturge bought 1.5m on the open market and 6m in the placing. | ducatiman | |
17/8/2018 14:51 | sold 100,000 really in protest.we need directors buying not selling. | ashtree2 | |
17/8/2018 14:44 | roughly £14,000 worth...not insignificant and came soon after the rns earlier in the week.not impressed. | ashtree2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions